66
BioTOPics 44 | May 2012
BioTOP-Report
Addresses
Biotech Companies
Molnar-Institut für angewandte
Chromatographie
Molnar-Institute, established in 1981, offers you a complete scientific and technical ser-
vice for all problems concerning Quality by Design (QbD) for HPLC-methods. We develop
for you the Design Space for your HPLC-separation and establish Critcal Quality Attributes
(CQA’s). We offer detailed DryLab-courses and show you, how to develop robust methods
in the Design Space and how to save time. We supply and implement the DryLab-software
and train your coworkers. We assist you in automated method development processes and
support you in the selection of proper instruments, their installation and use.
molnar-institute.com
MOLOGEN AG
MOLOGEN AG is a biopharmaceutical company based in Berlin and specializes in the de-
velopment of novel DNA-based medicines against cancer and vaccines against infectious
diseases. The proprietary platform technologies MIDGE
®
and dSLIM
®
build the foundation
for all business activities. The company was founded 1998 and was one of the first bio-
technology companies to go public.
mologen.com
MRI.TOOLS GmbH
MRI.TOOLS´s main focus is the development, sales and services of innovative hardware
and novel technology for magnetic resonance imaging (MRI), computed tomography (CT)
and positron emission tomography (PET). Our product portfolio encompasses enabling
radiofrequency (RF) coils tailored for a broad range of applications, devices designed for
reliable cardiac gating of imaging plus accessories that will make your daily life more com-
fortable. MRI.TOOLS is also very proud to offer consulting services such as validation and
certification of medical devices.
mritools.de
Nano Access Technologies Ltd.
The company addresses the combined access to key technologies such as life science and
nanotechnology. As a first product, a low cost AFM for operation with so-called active can-
tilevers has been developed. Besides this, functionalized cantilevers for future biosensors
are another focus of the company.
nano-access.com
Nanolytics Gesellschaft für
Kolloidanalytik mbH
We are a contract laboratory specializing in the physico-chemical characterization of phar-
maceutical proteins, biopolymers, nanoparticles and colloidal systems. Our core-compe-
tences are Analytical Ultracentrifugation, in combination with Static and Dynamic Light
Scattering as well as spectroscopic (CD, fluorescence) and thermodynamic techniques (ITC,
DSC).
nanolytics.de
Nanopartica GmbH
Nanopartica GmbH optimizes existing products of other companies, but are also develop-
ing new products and materials. In particular, companies in surface-, bio-, and medical-
technology can benefit from nanopartica. By means of functionalized polymers, we can
encapsulate guest molecules (drugs, dyes, vitamins), particles (gold, silver, platinum), or
ions. This will indirectly change the guests properties and expands its scope.
nanopartica.com
nanoPET Pharma GmbH
As a technology and service provider to the biopharmaceutical industry nanoPET focuses
on the R&D, production as well as marketing of innovative drug substances for diagnostic
imaging based on novel nanoparticular materials. nanoPET offers consulting and contract
research services, preclinical contrast agents (MRT, CT, US, NIR, PET) as catalog items and
pursues the preclinical development of its patented core technology of inorganic nanopar-
ticle PET tracers.
nanopet-pharma.com
NovaBiotec
®
Dr. Fechter GmbH
Microbiological and chemical investigations, in particular of soil, water and air samples,
planning / inspection of sanitation, in particular analytics and sanitation support for mould
and dry rot, incl. education in this field. Delivery of production auxilliaries and support for
biogas plants with biological treatment processes incl. application, insulation and preser-
vation of enzymes. Research, development and marketing of test kits for breweries and
malthouses.
novabiotec.de
Novamol GmbH
Development and manufacture of human and veterinary food supplements and health-
enhancing products.
novamol.com
NOXXON Pharma AG
NOXXON Pharma is a biopharmaceutical company pioneering the development of a new
class of proprietary therapeutics called Spiegelmers. Spiegelmers are the chemically syn-
thesized, non-immunogenic alternative to antibodies. NOXXON has a diversified portfolio
of clinical stage Spiegelmer therapeutics: Spiegelmer
®
NOX-E36, Spiegelmer
®
NOX-A12,
Spiegelmer
®
NOX-H94. The Spiegelmer platform provides the Company with powerful and
unique discovery capabilities, which have generated a number of additional leads under
preclinical investigation. Located in Berlin, Germany, NOXXON is a well financed mature
biotech company with a strong syndicate of international investors, approx. 60 employees
and a highly experienced management team.
noxxon.com
NutriNeu GmbH
NutriNeu GmbH develops a new generation of pre and probiotics. First products are based
on microorganisms that were isolated with our proprietary GlycoScreen technology (an-
tibody directed isolation of microorganisms expressing specific carbohydrate structures).
Besides developing own products, NutriNeu GmbH offers services in the fields of micro-
biology, process development and Glycoanalytic. NutriNeu GmbH also helps customers to
investigate the probiotic properties of their microorganisms.
OakLabs GmbH
OakLabs provides the most flexible products and services for large scale custom SNP ge-
notyping on the market. OakLabs offers several formats for analysing a variable number of
SNPs in any sequenced organism.
oak-labs.com